Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01257945 · ClinicalTrials.gov registry record · Phase 2
Exercise for People With Parkinson's Disease
A Phase 2 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 2
- Development phase
- 163
- Enrollment target
NCT01257945: Completed Phase 2 study, sponsored by University of Colorado, Denver.
NCT01257945 is a Phase 2 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 163 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (23% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01257945, a Phase 2 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 163 participants
- Enrollment target
Study Summary
This randomized, controlled exercise intervention with three groups compares two exercise approaches to standard of care. Supervised interventions are administered for four months, with emphasis on patients adopting exercise habits to continue to exercise for an additional 12 months. Functional outcomes are measured at the completion of the supervised exercise (4 months) as well as 10 and 16 months.
Primary Outcome
Measure of balance
Interventions
- BEHAVIORAL Aerobic Exercise
- BEHAVIORAL Home exercise program
- BEHAVIORAL Flexibility and Function exercise program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2003-04 |
| Est. Completion | 2010-07 |
| Phase | Phase 2 |
What the finished NCT01257945 record still lists
NCT01257945 is an interventional study that assigns participants to a tested intervention. The registered 163 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (23% higher).
The record links to 0 conditions, and to 3 interventions - of which Aerobic Exercise is the first listed.
NCT01257945 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01257945 about?
NCT01257945 is a clinical study titled "Exercise for People With Parkinson's Disease". This randomized, controlled exercise intervention with three groups compares two exercise approaches to standard of care. Supervised interventions are administered for four months, with emphasis on patients adopting exercise habits to continue to exercise for an additional 12 months. Functional outc...
What is the current status of trial NCT01257945?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 163 participants. The study started on 2003-04. Estimated completion is 2010-07.
What interventions are being tested in trial NCT01257945?
The interventions under investigation include: Aerobic Exercise (BEHAVIORAL), Home exercise program (BEHAVIORAL), Flexibility and Function exercise program (BEHAVIORAL).
Who is sponsoring clinical trial NCT01257945?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01257945's enrollment target sits among peer trials
163 418th of 2000 higher than 1,583 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03180268 · 163 participants · Phase 3
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- NCT04862221 · 163 participants · Phase 2
TReatment for ImmUne Mediated PathopHysiology
- NCT05702229 · 163 participants · Phase 2
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT06137118 · 163 participants · Phase 1
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia